Results 201 to 210 of about 177,862 (267)
A New Phenotype–Genotype Correlation for FIG4 and Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.
Iro Boura +4 more
wiley +1 more source
New‐Onset Psychosis in a Person with Parkinson's Disease after “Horny Goat Weed” Use
Movement Disorders Clinical Practice, EarlyView.
Juan R. Deliz +3 more
wiley +1 more source
Abstract Background Apathy is a common early symptom of Parkinson's disease (PD), often co‐occurring with cognitive decline and associated with fronto‐striatal and mesocortico‐limbic dysfunctions. Discrepancies between self‐ and caregiver‐reported apathy have been preliminarily associated with cognitive impairments affecting patients’ awareness and ...
Giulia Funghi +13 more
wiley +1 more source
GLP-1 Signalling as a Therapeutic Avenue in Parkinson's Disease: A Comprehensive Review. [PDF]
Orozco MP +2 more
europepmc +1 more source
Neurobehavioral alterations in HIV-1 transgenic rats: Evidence for dopaminergic dysfunction
Landhing M. Moran +3 more
openalex +2 more sources
Ocular Motor Abnormalities in Functional Neurological Disorder: A Video‐Oculography Study
Abstract Background Functional neurological disorders (FND) can include various sensory, motor or cognitive symptoms. Eye movement recordings, measured through video‐oculography, could serve as biomarkers for characterizing these dysfunctions in FND.
Aude Sangare +13 more
wiley +1 more source
Unraveling the intersection of aging and Parkinson's disease: a collaborative roadmap for advancing research models. [PDF]
Schmidt MY +14 more
europepmc +1 more source
Abstract Background Axial postural abnormalities (APAs) are common, disabling complications of Parkinson's disease (PD) with unclear pathophysiology. The presence of hyperactivity in multiple trunk muscles supports the use of botulinum toxin (BTA). However, its application is complex, due to the lack of standardized clinical and electrophysiological ...
Giacomo Argenziano +7 more
wiley +1 more source
Gut Microbiota and Dopamine: Producers, Consumers, Enzymatic Mechanisms, and In Vivo Insights. [PDF]
Albani G +8 more
europepmc +1 more source

